CAS No.13523-86-9,Pindolol Suppliers,MSDS download

Products Categories

Pharmaceutical (31)
Others (9)
Organic Chemicals (8)
Reagent (2)

Basic Information

Molecular Structure:
CAS No.:	13523-86-9
Name:	Pindolol
Article Data:	18

Formula:	C₁₄H₂₀N₂O₂
Molecular Weight:	248.325
Synonyms:	2-Propanol,1-(indol-4-yloxy)-3-(isopropylamino)- (8CI);(RS)-Pindolol;(?à)-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole;(?à)-LB 46;(?à)-Pindolol;1-[(1-Methylethyl)amino]-3-(4-indolyloxy)-2-propanol;4-(2-Hydroxy-3-isopropylaminopropoxy)indole;4-(3-Isopropylamino-2-hydroxypropoxy)indole;Apo-pindol;Betapindol;BlocklinL;Calvisken;Carvisken;DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole;DL-LB 46;DL-Pindolol;Decreten;Durapindol;Glauco-Visken;LB 46;LB 46(pharmaceutical);N-[2-Hydroxy-3-(1H-indol-4-yloxy)propyl]-N-isopropylamine;Pectobloc;Pinbetol;Pindolol;Prinodolol;Pynastin;Visken;
EINECS:	236-867-9
Density:	1.152 g/cm³
Melting Point:	167-171 °C(lit.)
Boiling Point:	457.132 °C at 760 mmHg
Flash Point:	230.265 °C
Solubility:	0.1 M NaOH: 0.2 mg/mL
Appearance:	white to off-white crystalline powder
Hazard Symbols:	Xn
Risk Codes:	22-36/37/38
Safety:	26-36
Transport Information:	UN 3249
PSA:	57.28000
LogP:	2.29650

Total:47 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 13523-86-9

Specification

The IUPAC name of Visken is 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol. With the CAS registry number 13523-86-9 and EINECS 236-867-9, it is also named as Pindolol. The product's categories are Heterocyclic Compounds; Pindolol; Serotonin Receptor. It is white to off-white crystalline powder which is easily soluble in acetic acid, slightly soluble in methanol, insoluble in water or benzene. When heated to decomposition it emits toxic fumes of NO_x.

The other characteristics of this product can be summarized as: (1)ACD/LogP: 1.97; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.06; (4)ACD/LogD (pH 7.4): 0.07; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 3.5; (9)#H bond acceptors: 4; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 7; (12)Polar Surface Area: 26.63 Å²; (13)Index of Refraction: 1.596; (14)Molar Refractivity: 73.41 cm³; (15)Molar Volume: 215.4 cm³; (16)Surface Tension: 47.5 dyne/cm; (17)Enthalpy of Vaporization: 75.57 kJ/mol; (18)Vapour Pressure: 3.77E-09 mmHg at 25°C; (19)Rotatable Bond Count: 6; (20)Exact Mass: 248.152478; (21)MonoIsotopic Mass: 248.152478; (22)Topological Polar Surface Area: 57.3; (23)Heavy Atom Count: 18; (24)Complexity: 248.

Preparation and Uses of Visken: It can be obtained by the amination of 4-(1,2-epoxypropoxy) indole and isopropylamine. Visken is a nonselective beta blocker with partial beta-adrenergic receptor agonist activity. What's more, it is sometimes added to a standard antidepressant therapy, if the patient fails to respond to the standard therapy alone.

When you are using this chemical, please be cautious about it as the following:
It is not only harmful if swallowed, but also irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. If you want to contact this product, you must wear suitable protective clothing.

People can use the following data to convert to the molecule structure.
1. SMILES:OC(CNC(C)C)COc1cccc2c1ccn2
2. InChI:InChI=1/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3
3. InChIKey:JZQKKSLKJUAGIC-UHFFFAOYAP

The following are the toxicity data which has been tested.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
man	TDLo	oral	71ug/kg/1D-I (0.071mg/kg)	BEHAVIORAL: TREMOR	Postgraduate Medical Journal. Vol. 56, Pg. 346, 1980.
mouse	LD50	intraperitoneal	80mg/kg (80mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 9, Pg. 3573, 1981.
mouse	LD50	intravenous	22600ug/kg (22.6mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 28, Pg. 794, 1978.
mouse	LD50	oral	235mg/kg (235mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Journal of Toxicological Sciences. Vol. 6, Pg. 301, 1981.
mouse	LD50	subcutaneous	336mg/kg (336mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
rabbit	LD50	intravenous	10mg/kg (10mg/kg)		Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
rabbit	LD50	oral	650mg/kg (650mg/kg)		Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
rat	LD50	intraperitoneal	110mg/kg (110mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973.
rat	LD50	intravenous	51mg/kg (51mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA	Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
rat	LD50	oral	263mg/kg (263mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
rat	LD50	subcutaneous	251mg/kg (251mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR	Niigata Igakkai Zasshi. Niigata Medical Journal. Vol. 84, Pg. 438, 1970.
women	TDLo	oral	300ug/kg/3D-I (0.3mg/kg)	BEHAVIORAL: TREMOR	Postgraduate Medical Journal. Vol. 56, Pg. 346, 1980.